BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Briukhovetska D, Dörr J, Endres S, Libby P, Dinarello CA, Kobold S. Interleukins in cancer: from biology to therapy. Nat Rev Cancer 2021;21:481-99. [PMID: 34083781 DOI: 10.1038/s41568-021-00363-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Chibaya L, Snyder J, Ruscetti M. Senescence and the tumor-immune landscape: Implications for cancer immunotherapy. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.02.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
2 Mertowska P, Mertowski S, Smarz-Widelska I, Grywalska E. Biological Role, Mechanism of Action and the Importance of Interleukins in Kidney Diseases. Int J Mol Sci 2022;23:647. [PMID: 35054831 DOI: 10.3390/ijms23020647] [Reference Citation Analysis]
3 Saetang J, Roongsawang N, Sangkhathat S, Voravuthikunchai SP, Sangkaew N, Prompat N, Srichana T, Tipmanee V. Surface cysteine to serine substitutions in IL-18 reduce aggregation and enhance activity. PeerJ 2022;10:e13626. [DOI: 10.7717/peerj.13626] [Reference Citation Analysis]
4 Ankawa R, Fuchs Y. May the best wound WIHN: the hallmarks of wound-induced hair neogenesis. Curr Opin Genet Dev 2021;72:53-60. [PMID: 34861514 DOI: 10.1016/j.gde.2021.10.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Hosseini R, Sarvnaz H, Arabpour M, Ramshe SM, Asef-Kabiri L, Yousefi H, Akbari ME, Eskandari N. Cancer exosomes and natural killer cells dysfunction: biological roles, clinical significance and implications for immunotherapy. Mol Cancer 2022;21:15. [PMID: 35031075 DOI: 10.1186/s12943-021-01492-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Afroze N, Pramodh S, Shafarin J, Bajbouj K, Hamad M, Sundaram MK, Haque S, Hussain A. Fisetin Deters Cell Proliferation, Induces Apoptosis, Alleviates Oxidative Stress and Inflammation in Human Cancer Cells, HeLa. Int J Mol Sci 2022;23:1707. [PMID: 35163629 DOI: 10.3390/ijms23031707] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Song F, Wang C, Wang C, Wang J, Wu Y, Wang Y, Liu H, Zhang Y, Han L. Multi-Phenotypic Exosome Secretion Profiling Microfluidic Platform for Exploring Single-Cell Heterogeneity. Small Methods 2022;:e2200717. [PMID: 35901289 DOI: 10.1002/smtd.202200717] [Reference Citation Analysis]
8 Shim S, Lee S, Hisham Y, Kim S, Nguyen TT, Taitt AS, Hwang J, Jhun H, Park H, Lee Y, Yeom SC, Kim S, Kim Y, Kim S. Comparison of the Seven Interleukin-32 Isoforms’ Biological Activities: IL-32θ Possesses the Most Dominant Biological Activity. Front Immunol 2022;13:837588. [DOI: 10.3389/fimmu.2022.837588] [Reference Citation Analysis]
9 Leiva O, AbdelHameid D, Connors JM, Cannon CP, Bhatt DL. Common Pathophysiology in Cancer, Atrial Fibrillation, Atherosclerosis, and Thrombosis: JACC: CardioOncology State-of-the-Art Review. JACC CardioOncol 2021;3:619-34. [PMID: 34988471 DOI: 10.1016/j.jaccao.2021.08.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
10 Di Nitto C, Neri D, Weiss T, Weller M, De Luca R. Design and Characterization of Novel Antibody-Cytokine Fusion Proteins Based on Interleukin-21. Antibodies 2022;11:19. [DOI: 10.3390/antib11010019] [Reference Citation Analysis]
11 Senent Y, Ajona D, González-Martín A, Pio R, Tavira B. The Complement System in Ovarian Cancer: An Underexplored Old Path. Cancers (Basel) 2021;13:3806. [PMID: 34359708 DOI: 10.3390/cancers13153806] [Reference Citation Analysis]
12 Guzzeloni V, Veschini L, Pedica F, Ferrero E, Ferrarini M. 3D Models as a Tool to Assess the Anti-Tumor Efficacy of Therapeutic Antibodies: Advantages and Limitations. Antibodies 2022;11:46. [DOI: 10.3390/antib11030046] [Reference Citation Analysis]
13 Nie W, Chen J, Wang B, Gao X. Nonviral vector system for cancer immunogene therapy. MedComm – Biomaterials and Applications 2022;1:mba2.10. [DOI: 10.1002/mba2.10] [Reference Citation Analysis]
14 Morris RM, Mortimer TO, O'Neill KL. Cytokines: Can Cancer Get the Message? Cancers (Basel) 2022;14:2178. [PMID: 35565306 DOI: 10.3390/cancers14092178] [Reference Citation Analysis]
15 Han ZJ, Li YB, Yang LX, Cheng HJ, Liu X, Chen H. Roles of the CXCL8-CXCR1/2 Axis in the Tumor Microenvironment and Immunotherapy. Molecules 2021;27:137. [PMID: 35011369 DOI: 10.3390/molecules27010137] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
16 Pretre V, Papadopoulos D, Regard J, Pelletier M, Woo J. Interleukin-1 (IL-1) and the inflammasome in cancer. Cytokine 2022;153:155850. [DOI: 10.1016/j.cyto.2022.155850] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
17 Raissa R, Riawan W, Safitri A, Masruri M, Beltran MAG, Aulanniam A. In vitro and in vivo study: Ethanolic extract leaves of Azadirachta indica Juss. variant of Indonesia and Philippines suppresses tumor growth of hepatocellular carcinoma by inhibiting IL-6/STAT3 signaling. F1000Res 2022;11:477. [DOI: 10.12688/f1000research.109557.1] [Reference Citation Analysis]
18 Plundrich D, Chikhladze S, Fichtner-Feigl S, Feuerstein R, Briquez PS. Molecular Mechanisms of Tumor Immunomodulation in the Microenvironment of Colorectal Cancer. Int J Mol Sci 2022;23:2782. [PMID: 35269922 DOI: 10.3390/ijms23052782] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Hassan G, Ohara T, Afify SM, Kumon K, Zahra MH, Fu X, Al Kadi M, Seno A, Salomon DS, Seno M. Different pancreatic cancer microenvironments convert iPSCs into cancer stem cells exhibiting distinct plasticity with altered gene expression of metabolic pathways. J Exp Clin Cancer Res 2022;41. [DOI: 10.1186/s13046-021-02167-3] [Reference Citation Analysis]
20 Shang Q, Dong Y, Su Y, Leslie F, Sun M, Wang F. Local scaffold-assisted delivery of immunotherapeutic agents for improved cancer immunotherapy. Adv Drug Deliv Rev 2022;185:114308. [PMID: 35472398 DOI: 10.1016/j.addr.2022.114308] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Kerr MWA, Magalhães-Gama F, Ibiapina HNS, Hanna FSA, Xabregas LA, Alves EB, Pimentel JPD, Carvalho MPSS, Tarragô AM, Teixeira-Carvalho A, Martins-Filho OA, da Costa AG, Malheiro A. Bone Marrow Soluble Immunological Mediators as Clinical Prognosis Biomarkers in B-Cell Acute Lymphoblastic Leukemia Patients Undergoing Induction Therapy. Front Oncol 2021;11:696032. [PMID: 34646761 DOI: 10.3389/fonc.2021.696032] [Reference Citation Analysis]
22 Shim S, Lee S, Hisham Y, Kim S, Nguyen TT, Taitt AS, Hwang J, Jhun H, Park HY, Lee Y, Yeom SC, Kim SY, Kim YG, Kim S. A Paradoxical Effect of Interleukin-32 Isoforms on Cancer. Front Immunol 2022;13:837590. [PMID: 35281008 DOI: 10.3389/fimmu.2022.837590] [Reference Citation Analysis]
23 Lantos J, Németh T, Barta Z, Szabó Z, Paróczai D, Varga E, Hartmann P. Pathophysiological Advantages of Spontaneous Ventilation. Front Surg 2022;9:822560. [DOI: 10.3389/fsurg.2022.822560] [Reference Citation Analysis]
24 Testa MTDJ, Cella PS, Marinello PC, Frajacomo FTT, Padilha CDS, Perandini PC, Moura FA, Duarte JA, Cecchini R, Guarnier FA, Deminice R. Resistance Training Attenuates Activation of STAT3 and Muscle Atrophy in Tumor-Bearing Mice. Front Oncol 2022;12:880787. [DOI: 10.3389/fonc.2022.880787] [Reference Citation Analysis]
25 Cheng EM, Tsarovsky NW, Sondel PM, Rakhmilevich AL. Interleukin-12 as an in situ cancer vaccine component: a review. Cancer Immunol Immunother 2022. [PMID: 35024897 DOI: 10.1007/s00262-022-03144-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Yang R, Han S, Clayton J, Haghighatian M, Tsai C, Yao Y, Li P, Shen J, Zhou Q. A Proof-of-Concept Inhibitor of Endothelial Lipase Suppresses Triple-Negative Breast Cancer Cells by Hijacking the Mitochondrial Function. Cancers 2022;14:3763. [DOI: 10.3390/cancers14153763] [Reference Citation Analysis]
27 Halin Bergström S, Lundholm M, Nordstrand A, Bergh A. Rat prostate tumors induce DNA synthesis in remote organs. Sci Rep 2022;12:7908. [PMID: 35551231 DOI: 10.1038/s41598-022-12131-6] [Reference Citation Analysis]
28 Tian Y, Xie D, Yang L. Engineering strategies to enhance oncolytic viruses in cancer immunotherapy. Signal Transduct Target Ther 2022;7:117. [PMID: 35387984 DOI: 10.1038/s41392-022-00951-x] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Klein S, Duda DG. Machine Learning for Future Subtyping of the Tumor Microenvironment of Gastro-Esophageal Adenocarcinomas. Cancers (Basel) 2021;13:4919. [PMID: 34638408 DOI: 10.3390/cancers13194919] [Reference Citation Analysis]
30 Xia T, Li J, Ren X, Liu C, Sun C. Research progress of phenolic compounds regulating IL-6 to exert antitumor effects. Phytother Res 2021. [PMID: 34427003 DOI: 10.1002/ptr.7258] [Reference Citation Analysis]
31 Venkatraman S, Balasubramanian B, Pongchaikul P, Tohtong R, Chutipongtanate S. Molecularly Guided Drug Repurposing for Cholangiocarcinoma: An Integrative Bioinformatic Approach. Genes 2022;13:271. [DOI: 10.3390/genes13020271] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Zhukova OV, Arkhipova EV, Kovaleva TF, Zykova DA, Dubovskaya NA. Effect of Poly(methacrylic acid) on the Cytokine Level in an In Vivo Tumor Model. Molecules 2022;27:4572. [DOI: 10.3390/molecules27144572] [Reference Citation Analysis]
33 Liu H, Wang R, An D, Liu H, Ye F, Li B, Zhang J, Liu P, Zhang X, Yao S, Zhong Z, Feng H, Feng M. An engineered IL-21 with half-life extension enhances anti-tumor immunity as a monotherapy or in combination with PD-1 or TIGIT blockade. Int Immunopharmacol 2021;101:108307. [PMID: 34735918 DOI: 10.1016/j.intimp.2021.108307] [Reference Citation Analysis]
34 Taniai T, Haruki K, Yanagaki M, Igarashi Y, Furukawa K, Onda S, Yasuda J, Matsumoto M, Tsunematsu M, Ikegami T. Osteosarcopenia predicts poor prognosis for patients with intrahepatic cholangiocarcinoma after hepatic resection. Surg Today 2022. [PMID: 35831486 DOI: 10.1007/s00595-022-02550-3] [Reference Citation Analysis]
35 Swati, Sharma V. The interplay of cytokine signaling and non-coding RNAs in head and neck squamous cell carcinoma pathobiology. Mol Biol Rep. [DOI: 10.1007/s11033-022-07770-x] [Reference Citation Analysis]
36 Humeau J, Le Naour J, Galluzzi L, Kroemer G, Pol JG. Trial watch: intratumoral immunotherapy. Oncoimmunology 2021;10:1984677. [PMID: 34676147 DOI: 10.1080/2162402X.2021.1984677] [Reference Citation Analysis]
37 Kim GT, Kim EY, Shin SH, Lee H, Lee SH, Sohn KY, Kim JW. Improving anticancer effect of aPD-L1 through lowering neutrophil infiltration by PLAG in tumor implanted with MB49 mouse urothelial carcinoma. BMC Cancer 2022;22:727. [PMID: 35787261 DOI: 10.1186/s12885-022-09815-7] [Reference Citation Analysis]
38 Wang S, Liu Y, Li J, Zhao L, Yan W, Lin B, Guo X, Wei Y. Fusobacterium nucleatum Acts as a Pro-carcinogenic Bacterium in Colorectal Cancer: From Association to Causality. Front Cell Dev Biol 2021;9:710165. [PMID: 34490259 DOI: 10.3389/fcell.2021.710165] [Reference Citation Analysis]
39 Hashimoto S, Kishimoto T. Roles of RNA-binding proteins in immune diseases and cancer. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.03.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Souza AG, Colli LM. Extracellular Vesicles and Interleukins: Novel Frontiers in Diagnostic and Therapeutic for Cancer. Front Immunol 2022;13:836922. [PMID: 35386696 DOI: 10.3389/fimmu.2022.836922] [Reference Citation Analysis]
41 Nisar M, Paracha RZ, Adil S, Qureshi SN, Janjua HA. An Extensive Review on Preclinical and Clinical Trials of Oncolytic Viruses Therapy for Pancreatic Cancer. Front Oncol 2022;12:875188. [PMID: 35686109 DOI: 10.3389/fonc.2022.875188] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Zhao X, Pradeep Si S. Biological Evaluation of Chinese Herbal Compounds as Anticancer Agents in Fighting Against Lung Cancer. International J of Pharmacology 2022;18:1244-51. [DOI: 10.3923/ijp.2022.1244.1251] [Reference Citation Analysis]
43 Pan L, Huang X, Liu ZX, Ye Y, Li R, Zhang J, Wu G, Bai R, Zhuang L, Wei L, Li M, Zheng Y, Su J, Deng J, Deng S, Zeng L, Zhang S, Wu C, Che X, Wang C, Chen R, Lin D, Zheng J. Inflammatory cytokine-regulated tRNA-derived fragment tRF-21 suppresses pancreatic ductal adenocarcinoma progression. J Clin Invest 2021;131:e148130. [PMID: 34779408 DOI: 10.1172/JCI148130] [Reference Citation Analysis]
44 Seaver K, Kourko O, Gee K, Greer PA, Basta S. IL-27 Improves Prophylactic Protection Provided by a Dead Tumor Cell Vaccine in a Mouse Melanoma Model. Front Immunol 2022;13:884827. [DOI: 10.3389/fimmu.2022.884827] [Reference Citation Analysis]
45 Xing C, Du Y, Duan T, Nim K, Chu J, Wang HY, Wang R. Interaction between microbiota and immunity and its implication in colorectal cancer. Front Immunol 2022;13:963819. [DOI: 10.3389/fimmu.2022.963819] [Reference Citation Analysis]
46 Flebbe H, Spitzner M, Marquet PE, Gaedcke J, Ghadimi BM, Rieken S, Schneider G, Koenig AO, Grade M. Targeting STAT3 Signaling Facilitates Responsiveness of Pancreatic Cancer Cells to Chemoradiotherapy. Cancers 2022;14:1301. [DOI: 10.3390/cancers14051301] [Reference Citation Analysis]
47 Bleuez C, Koch WF, Urbach C, Hollfelder F, Jermutus L. Exploiting protease activation for therapy. Drug Discovery Today 2022. [DOI: 10.1016/j.drudis.2022.03.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Kvedaraite E, Ginhoux F. Human dendritic cells in cancer. Sci Immunol 2022;7:eabm9409. [PMID: 35363544 DOI: 10.1126/sciimmunol.abm9409] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
49 Mishra AK, Singh SK, Dayanandan S, Banerjee S, Chakraborty S, Gopal AB, Samal S, Poirah I, Chakraborty D, Bhattacharyya A. Hypoxia-driven metabolic heterogeneity and immune evasive behaviour of gastrointestinal cancers: Elements of a recipe for disaster. Cytokine 2022;156:155917. [PMID: 35660715 DOI: 10.1016/j.cyto.2022.155917] [Reference Citation Analysis]
50 Carlsen L, Huntington KE, El-deiry WS. Immunotherapy for Colorectal Cancer: Mechanisms and Predictive Biomarkers. Cancers 2022;14:1028. [DOI: 10.3390/cancers14041028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
51 Holder PG, Lim SA, Huang CS, Sharma P, Dagdas YS, Bulutoglu B, Sockolosky JT. Engineering interferons and interleukins for cancer immunotherapy. Adv Drug Deliv Rev 2022;182:114112. [PMID: 35085624 DOI: 10.1016/j.addr.2022.114112] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
52 Propper DJ, Balkwill FR. Harnessing cytokines and chemokines for cancer therapy. Nat Rev Clin Oncol 2022. [PMID: 34997230 DOI: 10.1038/s41571-021-00588-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 24.0] [Reference Citation Analysis]
53 Akkın S, Varan G, Aksüt D, Malanga M, Ercan A, Şen M, Bilensoy E. A different approach to immunochemotherapy for colon Cancer: Development of nanoplexes of cyclodextrins and Interleukin-2 loaded with 5-FU. Int J Pharm 2022;623:121940. [PMID: 35724824 DOI: 10.1016/j.ijpharm.2022.121940] [Reference Citation Analysis]
54 Wu H, Hu D, Li Q, Wang C, Zhu X, Li W, Chen B, Ji P, Huang K, Huang A, Huang J, Dimitrov DS, Wu Y, Ying T. Half-life extension enhances drug efficacy in adeno-associated virus delivered gene therapy. Engineering 2022. [DOI: 10.1016/j.eng.2022.02.009] [Reference Citation Analysis]
55 Rehman AU, Olsson PO, Akhtar A, Padhiar AA, Liu H, Dai Y, Gong Y, Zhou Y, Khan N, Yang H, Tang L. Systematic molecular analysis of the human secretome and membrane proteome in gastrointestinal adenocarcinomas. J Cell Mol Med 2022. [PMID: 35488454 DOI: 10.1111/jcmm.17338] [Reference Citation Analysis]
56 Ni Y, Low JT, Silke J, O'Reilly LA. Digesting the Role of JAK-STAT and Cytokine Signaling in Oral and Gastric Cancers. Front Immunol 2022;13:835997. [PMID: 35844493 DOI: 10.3389/fimmu.2022.835997] [Reference Citation Analysis]
57 Hu WH, Chang CD, Liu TT, Chen HH, Hsiao CC, Kang HY, Chuang JH. Association of sarcopenia and expression of interleukin-23 in colorectal cancer survival. Clin Nutr 2021;40:5322-6. [PMID: 34536640 DOI: 10.1016/j.clnu.2021.08.016] [Reference Citation Analysis]